You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.
We guide you every step of the way, combining our deep clinical expertise in chronic myeloid leukemia (CML) with a commitment to meet your unique needs.
Why choose SCCA for CML treatment?
Comprehensive CML treatment
Our doctors are experts in your treatment options, including several drugs approved for CML since 2001. Based on the specific features of your disease, your team may recommend targeted therapy, chemotherapy, interferon or bone marrow transplant, all available at SCCA.
CML clinical trials
To give you access to the most innovative therapies, SCCA unites the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in CML clinical studies not available everywhere.
Pioneering new approaches
Researchers here pioneered a very important leukemia treatment, bone marrow transplant, and continue to refine it, making transplant an option for more people. We are also testing new cancer drugs, vaccines and combinations of treatments.
Bone marrow transplant for CML
The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We’ve performed more bone marrow transplants than any other institution in the world.
A national leader in cancer care
SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.
NCI comprehensive cancer center
We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.
Make an appointment
Call (855) 557-0555 to make an appointment, refer a patient or learn more about CML care at SCCA.